
The CDC's Advisory Committee on Immunization Practices (ACIP) recommends that all persons older than 60 years be immunized against herpes zoster with a single dose of the live, attenuated virus vaccine. Furthermore, it urges clinicians to offer the vaccine at the first available clinical encounter.



























































































































































